This invention provides compounds of formula I:
wherein R
1
, R
2
, R
3
, R
4
, R
5
, and R
6
are as described in the specification. The compounds are inhibitors of PLK and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.